Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2014
09/02/2014CA2575387C Novel peptide and pharmaceutical composition containing said peptide
09/02/2014CA2518608C Antimicrobial peptide and methods of use thereof
08/2014
08/28/2014WO2014131024A2 Agonists of guanylate cyclase and their uses
08/28/2014WO2014131019A2 Her-1, her-3 and igf-1r compositions and uses thereof
08/28/2014WO2014130949A1 Methods and compositions for the treatment of bone remodeling disorders
08/28/2014WO2014130811A1 Interferon beta formulation
08/28/2014WO2014130728A1 Norrin mutant polypeptides, methods of making and uses thereof
08/28/2014WO2014130723A1 Methods and compositions for treatment of pompe disease
08/28/2014WO2014130722A1 Methods and compositions for treatment of forbes-cori disease
08/28/2014WO2014130659A1 Chimeric fibroblast growth factor 23 proteins and methods of use
08/28/2014WO2014130657A1 Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor
08/28/2014WO2014130581A1 Acth for treatment of migraine headache
08/28/2014WO2014130529A1 In ovo administration of growth factors for improving poultry performance
08/28/2014WO2014130408A1 Regulators of rab5 activity
08/28/2014WO2014130007A1 Proteolytic compositions for rapidly and extensively degrading protein supplements
08/28/2014WO2014129969A1 Therapeutic agents
08/28/2014WO2014129914A1 Methods of treatment
08/28/2014WO2014128701A1 Interferon treatment targeting mutant p53 expressing cells
08/28/2014WO2014128611A1 Treatment of graft versus host disease in transplant patients
08/28/2014WO2014128257A1 Serpins: methods of therapeutic beta-cell regeneration and function
08/28/2014WO2014128254A1 Il-33 and treatment of neurodegenerative diseases
08/28/2014WO2014128233A1 Oral steroid formulations for use in the treatment of intestinal fibrosis
08/28/2014WO2014128173A1 Gm-csf for treatment of chronic oral mucositis
08/28/2014WO2014128079A1 Glatiramer acetate multidose formulation
08/28/2014WO2014127798A1 Functional peptides for obesity disorders
08/28/2014WO2014127479A1 Inhibition of sema3a in the prevention and treatment of ocular hyperpermeability
08/28/2014WO2014106492A3 Methods and compositions for treatment of bone, skin, subcutaneous, mucosal and/or submucosal cancer by percutaneous and/or transmucosal administration of interferon
08/28/2014WO2014096187A3 A cosmetic composition from fish hatching fluid, methods for its production and uses thereof for improving the cosmetic appearance of skin
08/28/2014WO2014043535A9 Compositions for the treatment of cancer
08/28/2014US20140243793 Delivery devices for nasopharyngeal mucosa targets
08/28/2014US20140243276 Smac mimetic (birinapant) for use in the treatment of proliferative diseases (cancer)
08/28/2014US20140243275 Galectin-3C Combination Therapy for Human Cancer
08/28/2014US20140243271 Therapeutic agent for rhinitis
08/28/2014US20140243270 Pharmaceutical composition containing neuregulin isoforms
08/28/2014US20140243269 Method of effecting neuroprotection using soluble neuregulin isoforms
08/28/2014US20140243267 Use of nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
08/28/2014US20140243264 Methods of treatment for retinal diseases
08/28/2014US20140243263 Method of enhancing diabetes resolution
08/28/2014US20140243261 Method for treating diabetes and fatty liver disese by stimulating cellular metabolism
08/28/2014US20140243260 Chimeric fibroblast growth factor 23 proteins and methods of use
08/28/2014US20140243259 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
08/28/2014US20140243258 Methods and compositions for targeting adipose cells in mammals
08/28/2014US20140243255 Treatments for mycobacterium tuberculosis
08/28/2014US20140242202 Composition for Reducing Side- and After-Effects of Cancer Treatment
08/28/2014US20140242194 Use of nitrite salts in treating tissue damage
08/28/2014US20140242184 Compositions for Regenerating Defective or Absent Myocardium
08/28/2014US20140242182 Formulations that stabilize proteins
08/28/2014US20140242158 Granular Pharmaceutical Composition
08/28/2014US20140242153 Novel encochleation methods, cochleates and methods of use
08/28/2014US20140242145 Chitosan nanofiber for anionic protein drug delivery, method of preparing the same, and pharmaceutical preparation for transmucosal administration comprising the chitosan nanofiber
08/28/2014US20140242142 Cell secreted proteins for the treatment of myocardial infarction
08/28/2014US20140242140 Fabrication method for stratified and layered tissue to repair osteochondral defects
08/28/2014US20140242124 Agonists of Guanylate Cyclase and Their Uses
08/28/2014US20140242106 Staphylococcus aureus proteins and nucleic acids
08/28/2014US20140242096 Compositions and methods related to graft versus host disease and treatments thereof
08/28/2014US20140242094 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
08/28/2014US20140242089 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
08/28/2014US20140242086 Polynucleotides encoding signal peptide-containing molecules
08/28/2014US20140242082 Combination therapy for the treatment of ocular neovascular disorders
08/28/2014US20140242074 Materials and methods for modulating activity of bone marrow derived cells
08/28/2014US20140242073 Cartilage/bone destruction suppressor
08/28/2014US20140242062 Modified proteases that inhibit complement activation
08/28/2014US20140242061 Compositions and methods for treating gaucher disease
08/28/2014US20140242059 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
08/28/2014US20140242058 St6gal i mediated modulation of hematopoiesis
08/28/2014US20140242051 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof
08/28/2014US20140242045 Methods And Compositions For Delivering Interleukin-1 Receptor Antagonist
08/28/2014US20140242030 Novel anti-hcv agent
08/28/2014US20140242029 Combination therapy for treating hcv infection in an hcv-hiv coinfected patient population
08/28/2014US20140242026 Compounds, compositions, and methods for preventing metastasis of cancer cells
08/28/2014US20140242007 Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo
08/28/2014US20140241983 Methods and Compositions for Enhancing the Therapeutic Effect of Anti-Tumor T Cells
08/28/2014US20140239526 Process for producing pellets for pharmaceutical compositions
08/27/2014EP2769990A2 Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
08/27/2014EP2769733A1 Stabilised mRNA encoding MUC1 against cancer
08/27/2014EP2769732A1 Serpins: methods of therapeutic beta-cell regeneration and function
08/27/2014EP2769731A1 Methods to activate or block the HLA-E/QA-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
08/27/2014EP2769717A1 A composition comprising reduced glutathione and acetaminophen and preparation method thereof
08/27/2014EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto
08/27/2014EP2769220A1 Biomarker
08/27/2014EP2768958A1 Amine cationic lipids and uses thereof
08/27/2014EP2768856A1 Peg conjugates of exenatide
08/27/2014EP2768853A1 Method for improving the stability of purified factor viii after reconstitution
08/27/2014EP2768852A1 Peptide compounds derived from melanotransferrin and uses thereof
08/27/2014EP2768849A1 Novel plant defensins and use in the treatment of proliferative diseases
08/27/2014EP2768541A1 Method of forming dextran and thrombin sheets
08/27/2014EP2768540A1 Method of forming hemostatic products
08/27/2014EP2768534A1 Antigen presenting cancer vaccine
08/27/2014EP2768526A1 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
08/27/2014EP2768523A1 Method of treating or reducing efp
08/27/2014EP2768522A1 Use of sulfated glycosaminoglycans for improving the bioavailability of factor viii
08/27/2014EP2768521A1 Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor viii
08/27/2014EP2768520A1 Chemically and thermodynamically stable insulin analogues and improved methods for their production
08/27/2014EP2768519A2 Antigen presenting cancer vaccine with gamma interferon
08/27/2014EP2768518A1 Peptidomimetic macrocyles
08/27/2014EP2768517A2 Hepatitis c virus inhibitors
08/27/2014EP2768516A1 Aromatic-cationic peptides and uses of same
08/27/2014EP2768490A1 Stabilizers for hemostatic products
08/26/2014US8816054 Compositions and methods for enhancing coagulation Factor VIII function
08/26/2014US8816053 Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 3163